Pharma

This pioneering collaboration brings together GBU’s academic research strengths with the translation and commercialization experience of Cellimune Biotech CAR-T therapy...

The team developed 5n, a potential prostate cancer inhibitor, to disrupt cancer’s survival tactics through molecular sabotage  The molecule disables...

Revenue from operations at 6,528 crore, up 18% over last year. Research & Development (R&D) investments Rs. 479.9 crore (7.4%...

With top recruiters on campus and a Rs 9L per annum peak offer, Swarrnim balances strong placements with a thriving...

It is the generic version of Copaxone® 20 mg/ml, 40 mg/ml, Single-Dose Prefilled Syringes Zydus’ generic Glatiramer Acetate Injection, developed...

Alembic has a cumulative total of 222 ANDA approvals (197 final approvals and 25 tentative approvals) from USFDA NE BUSINESS...

Prof. Ratan Kumar Parimu-NE photo Of them four were conferred with Padma Vibhushan, 10 with Padma...

As indicated in the joint announcement of March 11, 2025, the completion of the Block Acquisition remains subject to the...

Developed by Cadila Pharmaceuticals’ in-house research and development team, ThRabis® was launched in April 2022 and has since been rolled...

Zydus MedTech Private Limited (Zydus Medtech) gets rights to market the innovative Transcatheter Aortic Valve Implantation (TAVI) technology in India,...